SCR-LIP-000646 · Claim · machine-readable JSON →

Genome-wide studies suggest common genetic variants may contribute modestly to lipedema susceptibility.

General proposition consolidated from 4 earlier single-paper claims; each study's own result is shown as its finding.

Claim at a glance
Type
clinical association
Knowledge state
Emerging
Evidence certainty
moderate (GRADE)
Evidence
5 source(s) · by Amato
Dates
2026-11-20 → 2026-11-20

Structured evidence, machine-compiled — not a verdict.

Evidence over time

20202025Amato ACM, 2020 · contextualInvestigation of clinical characteristics and genome associations in the ‘UK Lipoedema’ cohort — Grigoriadis et al. (2021) · contextualInvestigation of clinical characteristics and genome associations in the ‘UK Lipoedema’ cohort — Grigoriadis et al. (2022) · consistentGenome-wide association study of a lipedema phenotype among women in the UK Biobank identifies multiple genetic risk factors — Klimentidis et al. (2023) · consistentUnraveling lipedema: comprehensive insights and the path to future discoveries — Faria et al. (2025) · contextual

Evidence (5)

Context (PECO)

Populationwomen with inferred lipedema phenotype, UK Biobank
Conditionlipedema
Exposuregenome-wide significant loci (e.g., RSPO3, VEGFA, ADAMTS9)
Comparatorpopulation-level GWAS controls
Outcomelipedema genetic risk loci and SNP heritability
Scopeauto-ingested from Layer 1 surveillance

Answers these questions

Gaps & caveats

Change log